Kutatási jelek – Signal Engine

• New strategies in ovarian cancer treatment — Ovarian cancer
• Pembrolizumab plus chemotherapy for cervical cancer — Cervical cancer
• Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04 — Anal squamous cell carcinoma
• A Clinical Study of MK-3120 in People With... — Bladder cancer
• Single-cell and spatial transcriptomics reveal lactate-active epithelial‑immune cell crosstalk that reprograms the immune microenvironment in colorectal cancer — Colorectal cancer
• STAT3 Signaling Inhibitors for Cancer Treatment — Colorectal cancer
• Novel Target Combinations in Lung Squamous Cell Carcinoma proposed by the Emet AI Research Environment and supported by discovery stage experimentation — NSCLC
• Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators. — Endometrial cancer
• Targeted Therapy Improves Pancreatic Cancer Survival — Pancreatic cancer
• A New Drug, DT2216, Combined With Paclitaxel for Recurrent Platinum-Resistant Ovarian Cancer — Ovarian cancer
• Fighting Ovarian Cancer Through Awareness, Equity, and Research — Ovarian cancer
• ‘Truly shocking’: Nearly one-third of young women unscreened for cervical cancer — Cervical cancer
• Clinical Trials in Metastatic Uveal Melanoma: Current Status — Melanoma
• Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland — Nasopharyngeal carcinoma
• Osteosarcoma vs. Ewing Sarcoma: How Diagnosis and Treatment Differ — Osteosarcoma
• Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group — Ewing sarcoma
• Analysis of prognostic factors in patients with locally advanced cervical squamous cell carcinoma and development of a nomogram prediction model — Hepatocellular carcinoma
• A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) — Myelofibrosis
• Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research — Diffuse large B-cell lymphoma
• Association of rituximab with survival outcomes in primary testicular diffuse large B-cell lymphoma: a systematic review and meta-analysis of retrospective studies — Diffuse large B-cell lymphoma